These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

499 related articles for article (PubMed ID: 34653533)

  • 1. Understanding and improving cellular immunotherapies against cancer: From cell-manufacturing to tumor-immune models.
    Ringquist R; Ghoshal D; Jain R; Roy K
    Adv Drug Deliv Rev; 2021 Dec; 179():114003. PubMed ID: 34653533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging role of autophagy in anti-tumor immunity: Implications for the modulation of immunotherapy resistance.
    Jiang T; Chen X; Ren X; Yang JM; Cheng Y
    Drug Resist Updat; 2021 May; 56():100752. PubMed ID: 33765484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunotherapy discovery on tumor organoid-on-a-chip platforms that recapitulate the tumor microenvironment.
    Zhang J; Tavakoli H; Ma L; Li X; Han L; Li X
    Adv Drug Deliv Rev; 2022 Aug; 187():114365. PubMed ID: 35667465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Taking a Full Snapshot of Cancer Biology: Deciphering the Tumor Microenvironment for Effective Cancer Therapy in the Oncology Clinic.
    Dzobo K
    OMICS; 2020 Apr; 24(4):175-179. PubMed ID: 32176591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hijacked Immune Cells in the Tumor Microenvironment: Molecular Mechanisms of Immunosuppression and Cues to Improve T Cell-Based Immunotherapy of Solid Tumors.
    Balta E; Wabnitz GH; Samstag Y
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34072260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multi-Omics Profiling of the Tumor Microenvironment.
    Van Oekelen O; Laganà A
    Adv Exp Med Biol; 2022; 1361():283-326. PubMed ID: 35230695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Novel Hydrogel-Based 3D In Vitro Tumor Panel of 30 PDX Models Incorporates Tumor, Stromal and Immune Cell Compartments of the TME for the Screening of Oncology and Immuno-Therapies.
    Xue B; Schüler J; Harrod CM; Lashuk K; Bomya Z; Hribar KC
    Cells; 2023 Apr; 12(8):. PubMed ID: 37190054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanoimmunology in the solid tumor microenvironment.
    Golo M; Newman PLH; Kempe D; Biro M
    Biochem Soc Trans; 2024 Jun; 52(3):1489-1502. PubMed ID: 38856041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ex Vivo Tumor-on-a-Chip Platforms to Study Intercellular Interactions within the Tumor Microenvironment.
    Kumar V; Varghese S
    Adv Healthc Mater; 2019 Feb; 8(4):e1801198. PubMed ID: 30516355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 3D bioprinted tumor model: a prompt and convenient platform for overcoming immunotherapy resistance by recapitulating the tumor microenvironment.
    Zhang Z; Chen X; Gao S; Fang X; Ren S
    Cell Oncol (Dordr); 2024 Aug; 47(4):1113-1126. PubMed ID: 38520648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Engineered 3D ex vivo models to recapitulate the complex stromal and immune interactions within the tumor microenvironment.
    Ravi K; Manoharan TJM; Wang KC; Pockaj B; Nikkhah M
    Biomaterials; 2024 Mar; 305():122428. PubMed ID: 38147743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor Microenvironment and Nitric Oxide: Concepts and Mechanisms.
    Vedenko A; Panara K; Goldstein G; Ramasamy R; Arora H
    Adv Exp Med Biol; 2020; 1277():143-158. PubMed ID: 33119871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic Regulation of Tregs in Cancer: Opportunities for Immunotherapy.
    Wang H; Franco F; Ho PC
    Trends Cancer; 2017 Aug; 3(8):583-592. PubMed ID: 28780935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mimicking tumor microenvironment by 3D bioprinting: 3D cancer modeling.
    Shukla P; Yeleswarapu S; Heinrich MA; Prakash J; Pati F
    Biofabrication; 2022 May; 14(3):. PubMed ID: 35512666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of costimulatory and inhibitory receptors in FoxP3
    Toker A; Ohashi PS
    Adv Cancer Res; 2019; 144():193-261. PubMed ID: 31349899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The roles of mast cells in anticancer immunity.
    Dalton DK; Noelle RJ
    Cancer Immunol Immunother; 2012 Sep; 61(9):1511-20. PubMed ID: 22527244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Janus Face of Tumor Microenvironment Targeted by Immunotherapy.
    Buoncervello M; Gabriele L; Toschi E
    Int J Mol Sci; 2019 Sep; 20(17):. PubMed ID: 31484464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unlocking the potential of the tumor microenvironment for cancer therapy.
    Tufail M
    Pathol Res Pract; 2023 Nov; 251():154846. PubMed ID: 37837860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular interactions in tumor microenvironment during breast cancer progression: new frontiers and implications for novel therapeutics.
    Akinsipe T; Mohamedelhassan R; Akinpelu A; Pondugula SR; Mistriotis P; Avila LA; Suryawanshi A
    Front Immunol; 2024; 15():1302587. PubMed ID: 38533507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives.
    Mao X; Xu J; Wang W; Liang C; Hua J; Liu J; Zhang B; Meng Q; Yu X; Shi S
    Mol Cancer; 2021 Oct; 20(1):131. PubMed ID: 34635121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.